NCT02182297View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 201335 NA in single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02182297 - Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects | Biotech Hunter | Biotech Hunter